REPLIGEN CORP Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
REPLIGEN CORP (RGEN) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $1.15 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2016-02-25
- REPLIGEN CORP unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2015-12-31 was $1.01M.
- REPLIGEN CORP unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2015 was $1.15M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 3 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 9 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|---|---|
| 2015-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.15M 10-K · filed 2016-02-25 | |
| 2015-09-30 | $141.00K 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |